Aerobic Exercise Training Exerts Beneficial Effects Upon Oxidative Metabolism and Non-Enzymatic Antioxidant Defense in the Liver of Leptin Deficiency Mice

Non-alcoholic fatty liver disease (NAFLD) is one of the most common forms of liver disease, which is associated with several etiological factors, including stress and dysfunction in oxidative metabolism. However, studies showed that aerobic exercise training (AET) can combat the oxidative stress (OS) and improves mitochondrial functionality in the NAFLD. To test the hypothesis that AET improves oxidative metabolism and antioxidant defense in the liver of ob/ob mice. Male ob/ob mice with eight weeks old were separated into two groups: the sedentary group (S), n=7, and the trained group (T), n=7. The T mice were submitted to an 8-week protocol of AET at 60% of the maximum velocity achieved in the running capacity test. Before AET, no difference was observed in running test between the groups (S=10.4 +/- 0.7 min vs. T= 13 +/- 0.47 min). However, after AET, the running capacity was increased in the T group (12.8 +/- 0.87 min) compared to the S group (7.2 +/- 0.63 min). In skeletal muscle, the T group (26.91 +/- 1.12 U/mg of protein) showed higher citrate synthase activity compared with the S group (19.28 +/- 0.88 U/mg of protein) (p =0.006). In the analysis of BW evolution, significant reductions were seen in the T group as of the fourth week when compared to the S group. In addition, food intake was not significant different between the groups. Significant increases were observed in the activity of enzymes citrate synthase (p=0.004) and beta-HAD (p=0.01) as well as in PGC-1 alpha gene expression (p=0.002) in the liver of T group. The levels of TBARs and carbonyls, as well as SOD, CAT and GST were not different between the groups. However, in the nonenzymatic antioxidant system, we found that the T group had higher sulfhydryl (p = 0.02), GSH (p=0.001) and GSH/GSSG (p=0.02) activity. In conclusion, the AET improved body weight evolution and the aerobic capacity, increased the response of oxidative metabolism markers in the liver such as PGC-1 alpha gene expression and citrate synthase and beta-HAD enzyme activities in ob/ob mice. In addition, AET improved the non-enzymatic antioxidant defense and did not change the enzymatic defense.

Palavras-chave

liver disease, oxidative metabolism, antioxidant defense, physical exercise, leptin deficiency

URI

https://observatorio.fm.usp.br/handle/OPI/39214

Referências

AEBI H, 1984, METHOD ENZYMOL, V105, P121
Al-Dayyat HM, 2018, DIABETES METAB SYND, V12, P569, DOI 10.1016/j.dsx.2018.03.016
ALP PR, 1976, BIOCHEM J, V154, P689, DOI 10.1042/bj1540689
Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004
Buege J A, 1978, Methods Enzymol, V52, P302
Couto N, 2016, FREE RADICAL BIO MED, V95, P27, DOI 10.1016/j.freeradbiomed.2016.02.028
De Souza CT, 2010, J PHYSIOL-LONDON, V588, P2239, DOI 10.1113/jphysiol.2009.183996
ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
Erlich AT, 2016, INTEGR MED RES, V5, P187, DOI 10.1016/j.imr.2016.05.003
Evangelista FS, 2015, INT J CLIN EXP MED, V8, P10911
Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x
Georgoulis M, 2015, NUTR RES, V35, P41, DOI 10.1016/j.nutres.2014.11.004
Goncalves IO, 2014, MITOCHONDRION, V15, P40, DOI 10.1016/j.mito.2014.03.012
Goncalves IO, 2013, EUR J CLIN INVEST, V43, P1184, DOI 10.1111/eci.12146
Grattagliano I, 2008, J NUTR BIOCHEM, V19, P491, DOI 10.1016/j.jnutbio.2007.06.011
HABIG WH, 1974, J BIOL CHEM, V249, P7130
Halliwell B, 2015, FREE RADICALS BIOL M, V5th ed
HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
Ito M, 2010, AM J PHYSIOL-HEART C, V298, pH1426, DOI 10.1152/ajpheart.00284.2009
Ko Jinho, 2013, J Exerc Nutrition Biochem, V17, P181, DOI 10.5717/jenb.2013.17.4.181
Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200
Kudryavtseva AV, 2016, ONCOTARGET, V7, P44879, DOI 10.18632/oncotarget.9821
Le Page C, 2009, EXP GERONTOL, V44, P177, DOI 10.1016/j.exger.2008.10.003
LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
Linden MA, 2015, MED SCI SPORT EXER, V47, P556, DOI 10.1249/MSS.0000000000000430
Lohr K, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12988
Loomba R, 2015, J HEPATOL, V63, P10, DOI 10.1016/j.jhep.2015.03.009
Magkos F, 2010, CURR OPIN LIPIDOL, V21, P507, DOI 10.1097/MOL.0b013e32833ea912
Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029
MISRA HP, 1972, J BIOL CHEM, V247, P3170
Molero JC, 2006, DIABETES, V55, P708, DOI 10.2337/diabetes.55.03.06.db05-0312
Morris EM, 2017, J PHYSIOL-LONDON, V595, P4909, DOI 10.1113/JP274281
Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132
Nascimento L, 2014, APPL PHYSIOL NUTR ME, V39, P880, DOI 10.1139/apnm-2013-0452
Perfield JW, 2013, J OBES, V2013, DOI 10.1155/2013/296537
Rani V, 2016, LIFE SCI, V148, P183, DOI 10.1016/j.lfs.2016.02.002
Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71
REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
Rinella ME, 2016, NAT REV GASTRO HEPAT, V13, P196, DOI 10.1038/nrgastro.2016.3
Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
SEN CK, 1994, J APPL PHYSIOL, V77, P2177
SEN CK, 1995, J APPL PHYSIOL, V79, P675
Shin SK, 2018, PFLUG ARCH EUR J PHY, V470, P1721, DOI 10.1007/s00424-018-2195-z
Silva LLSE, 2020, CLIN EXP GASTROENTER, V13, P223, DOI 10.2147/CEG.S242393
Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060

Coleções

Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - LIM/13
Artigos e Materiais de Revistas Científicas - LIM/37

Página do item completo